Elizabeth Holmes, once seen as the next Steve Jobs, starts her 11-year prison sentence today.
Theranos, her biotech startup valued at $10 billion, is infamous for its downfall.
The startup claimed to have developed revolutionary blood testing technology but it was later revealed as inaccurate.
The US government launched an investigation into Theranos in 2016, which lasted for nearly two years.
In November 2022, Holmes was sentenced to more than 11 years in prison for defrauding investors.
Theranos raised over $700 million from venture capitalists and private investors, reaching a peak valuation of $10 billion.
The company's blood testing technology was exposed as faulty by a Wall Street Journal reporter, John Carreyrou.
Patients who used Theranos machines received false positive results for conditions like cancer and HIV.
Carreyrou's investigative reports revealed the false claims made by Theranos and the limitations of its technology.
Holmes was found guilty of defrauding investors on four out of eleven counts, while former COO Ramesh Balwani was found guilty on all counts.
Theranos serves as a cautionary tale about the dangers of startup culture and the importance of due diligence.